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Abstract
Background: We hypothesized that the frequencies of risk alleles of SNPs mediating susceptibility to cardiovascular
diseases differ among populations of varying geographic origin and that population-specific selection has operated
on some of these variants.
Methods: From the database of genome-wide association studies (GWAS), we selected 36 cardiovascular
phenotypes including coronary heart disease, hypertension, and stroke, as well as related quantitative traits (eg,
body mass index and plasma lipid levels). We identified 292 SNPs in 270 genes associated with a disease or trait at
P <5×1 0
-8. As part of the Human Genome-Diversity Project (HGDP), 158 (54.1%) of these SNPs have been
genotyped in 938 individuals belonging to 52 populations from seven geographic areas. A measure of population
differentiation, FST, was calculated to quantify differences in risk allele frequencies (RAFs) among populations and
geographic areas.
Results: Large differences in RAFs were noted in populations of Africa, East Asia, America and Oceania, when
compared with other geographic regions. The mean global FST (0.1042) for 158 SNPs among the populations was
not significantly higher than the mean global FST of 158 autosomal SNPs randomly sampled from the HGDP
database. Significantly higher global FST (P < 0.05) was noted in eight SNPs, based on an empirical distribution of
global FST of 2036 putatively neutral SNPs. For four of these SNPs, additional evidence of selection was noted
based on the integrated Haplotype Score.
Conclusion: Large differences in RAFs for a set of common SNPs that influence risk of cardiovascular disease were
noted between the major world populations. Pairwise comparisons revealed RAF differences for at least eight SNPs
that might be due to population-specific selection or demographic factors. These findings are relevant to a better
understanding of geographic variation in the prevalence of cardiovascular disease.
Keywords: cardiovascular disease genetics, genome-wide association study, risk allele frequency, population
differentiation
Background
Although ethnic and geographic differences in the rates
of cardiovascular disease are well known [1,2], the basis
for such differences is not fully understood and the pos-
sible contribution of genetic factors has not been inves-
tigated. Genome-wide association studies (GWAS) have
led to the identification of multiple genetic susceptibility
variants (mostly single nucleotide polymorphisms, SNPs)
for common diseases, such as atherosclerotic vascular
disease [3]. However, most of the susceptibility SNPs
were identified from populations of European ancestry.
It is not known whether such SNPs also mediate sus-
ceptibility in other populations, whether the risk allele
frequencies (RAFs) of these SNPs differ among the glo-
bal populations, and whether these differences are due
to forces of population-specific selection (ie, local
selection).
An evolutionary perspective might explain why con-
temporary humans are at high risk for atherosclerotic
vascular disease and help to better understand
geographic variation in disease susceptibility [4]. Since
geographically separated populations might be subject to
distinctive selective environments, population-specific
selection can increase population differentiation at the * Correspondence: kullo.iftikhar@mayo.edu
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between geographic regions are more likely to have
resulted from genetic drift during population expansion
after a bottleneck rather than by natural selection, a
phenomenon also known as ‘allelic surfing’ [5-7]. From
a genetic epidemiology perspective, it is of interest to
explore whether RAF differences exist for susceptibility
variants for cardiovascular disease, and if so, whether
the differences can be accounted by allelic surfing or by
natural selection.
In order to elucidate the evolutionary mechanisms
that may have influenced the history and spread of
genes/variants associated with cardiovascular disease
and related risk factors, we calculated differences in
RAFs within and out of a region of interest, and tested
the population differentiation of SNPs identified in
GWAS as influencing risk of cardiovascular disease. We
hypothesized that SNPs mediating susceptibility to car-
diovascular disease differ in frequency between human
populations and may show evidence for population-
specific selection.
Methods
GWAS of cardiovascular disease phenotypes and related
quantitative traits
The GWAS database [8] (accessed on Sep. 6
th 2009)
includes 211 distinct disease and traits, as well as >1,500
associated SNPs. From this database, we selected 36 car-
diovascular diseases and traits, including coronary heart
disease, stroke, and hypertension, and quantitative traits
(ie, body mass index blood pressure and plasma lipid
levels). A detailed description of selection of the cardio-
vascular disease phenotypes and related quantitative
traits is provided in the Additional file 1. We identified
292 SNPs in 270 genes associated with a disease or trait
at P <5×1 0
-8. The risk allele was ascertained from ori-
ginal reports, eg, the allele associated with either an
odds ratio >1 for disease phenotypes or with higher
levels of body mass index, low-density lipoprotein (LDL)
cholesterol, triglycerides and blood pressure, and lower
levels of high-density lipoprotein (HDL) cholesterol.
Genotype data
For our population genetics analyses, we obtained geno-
type data from the Human Genome Diversity Project
(HGDP) [9], as part of which 642,690 SNPs were geno-
typed in 938 unrelated individuals from 52 populations
[10]. The 52 populations belong to seven geographic
areas: African, Middle East, Europe, Central and South
Asia, East Asia, America, and Oceania (Additional file 2).
Of 292 SNPs, genotype data for 158 SNPs (54.1%) were
available in the HGDP database and analyzed in the pre-
sent study (Additional file 3).
Statistical analysis
We calculated the global and regional risk allele fre-
quency (RAF) for each SNP. For risk allele i of each
SNP, we computed the average RAF (¯ pij) within each
geographic area j, as well as the difference with the aver-
age RAF computed over all other populations as
F = ¯ p−ij − ¯ pij,w h e r e¯ p−ij is the average RAF of allele i
in all populations not belonging to the geographic
region j. We used the method of Hofer et al. [6] to ran-
domly permute populations (10,000 times) between geo-
graphic areas and recomputed ΔF each time, to obtain
its null distribution and test for the significance of ΔF
for each risk allele.
The measure of population differentiation (FST)w a s
calculated as described by Weir [11], using a Perl script
that we had previously developed [12]. We calculated
the global FST among 52 populations and this served as
a summary of the global population differentiation. In
addition, the FST among the seven geographical areas (7
× 7 matrices, populations in the same geographical area
were combined), and pairwise FST in any two popula-
tions (52 × 52 matrices) were calculated. In order to test
whether the mean FST of the 158 susceptibility SNPs
was significantly different from that of random markers,
we selected 158 random SNPs with allele frequency dis-
tribution similar to that of 158 susceptibility SNPs 1,000
times. The mean FST of the 158 susceptibility SNPs was
compared to the distribution of mean FST of the 158
random SNPs.
To assess the statistical significance of differences in
FST across populations, an empirical distribution of FST
was estimated by selecting 2036 autosomal markers
from HGDP database. The 2036 random markers
located within intergenic regions, were selected based
on the annotation tables of human chromosomes
(http://genome.ucsc.edu). These regions were separated
by at least 1 MB from the closest exon, did not include
centromeric regions, and provide an appropriate null
distribution for spatial patterns of variation expected for
putatively neutral regions [12]. Each FST value was com-
pared to the corresponding empirical distribution of FST
values to generate a P value, which was corrected for
minor allele frequency by comparing only to SNPs (n =
2036) from the empirical distribution that fell into the
same minor allele frequency bin (Pcor) [13]. For SNPs
with a significantly higher global FST,w ea l s oo b t a i n e d
the integrated Haplotype Score (iHS) statistic using the
HGDP selection browser [14,15]. The iHS statistic is
based on the differential levels of LD surrounding a
positively selected allele compared to a background
allele at the same position [16].
We assessed the geographic patterns of pairwise FST
based on geographic distance and human migration
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for each pair of populations is described further in
Additional file 1. A linear regression coefficient was cal-
culated from the scatterplot of pairwise FST against geo-
graphic distances.
Results
Distribution of risk allele frequencies (RAFs)
We first characterized the distribution of RAFs for sus-
ceptibility SNPs for cardiovascular disease and related
risk factors. The RAFs varied significantly among the
populations, from being either ‘fixed’ (RAF = 1) or
‘missed’ (RAF = 0). A summary of the maximum differ-
ences of RAFs (ie, the largest difference of all the pair-
wise population comparisons) between any 2 of the 52
populations for each SNP is presented in Figure 1A.
Seventy-two risk alleles were ‘fixed’ in at least one popu-
lation whereas 86 risk alleles were ‘missed’ in at least
one population.
We then determined the prevalence of large RAF dif-
ferences between geographic regions. We tested whether
populations belonging to the same geographic area have
more similar RAFs than expected by chance, either due
to shared demographic history or due to shared selective
events, as suggested by Hofer et al. [6]. Figure 1B sum-
marizes the distribution of differences of the average of
RAFs in one of the tested geographic areas, as well as
the differences with the average RAFs computed over all
other populations (ie, F = ¯ p−ij − ¯ pij). A negative ΔF
indicates that the RAF is higher within the tested geo-
graphic area than in the rest of the world. We used an
arbitrary threshold (ΔF >0 . 3o rΔF < -0.3) to define a
large RAF difference [6]. Large differences in RAF
between geographic areas were frequent: 69 out of 158
(43.7%) risk alleles have ΔF >0 . 3o rΔF <- 0 . 3f o ra t
least one comparison. Of the seven geographic regions,
Africa, East Asia, America, and Oceania showed the lar-
gest number of loci with large RAF differences (Addi-
tional file 4). As expected under the out-of-Africa
hypothesis, the differences in RAF are strikingly large
when comparing Africa with the remaining geographic
regions. The largest observed ΔF (0.731) was found
between American and non-American populations for
the SNP ‘rs174570’ in FADS2 (a gene that regulates
unsaturation of fatty acids); the RAF in the native Amer-
ican population (0.048) was much lower than in the
remaining populations (0.779).
Global population differentiation
We calculated the global FST as a measure of allele fre-
quency differences across the 52 populations (Figure
2A). The mean global FST for the 158 cardiovascular
susceptibility SNPs was 0.1042, not significantly larger
than the mean global FST of 158 randomly sampled
SNPs (P = 0.064) (Figure 2B), indicating that overall, the
158 SNPs associated with cardiovascular diseases were
not more differentiated than random markers. We
assessed the statistical significance for each susceptibility
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Figure 1 Distribution of risk allele frequency (RAF) in HGDP populations. A. Differences in RAFs between any 2 of the 52 populations in
the HGDP panel for the 158 SNPs associated with cardiovascular-diseases traits. B. Differences of RAF (F = ¯ p−ij − ¯ pij) for the comparison of a
given tested region (eg, Africa) versus the rest of the world. Negative ΔF indicates that the risk allele has a higher frequency within the tested
population than in the rest of the world (see methods section for the denotation of ¯ p−ij and ¯ pij).
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tribution of global FST for 2036 autosomal intergenic
SNPs from the HGDP database (Figure 2C) [12].
Among 158 SNPs, eight SNPs had a statistically signifi-
cantly higher FST (FST >0 . 2 0 3 ;P < 0.05) (Table 1) even
after correcting for allele frequency. Three of these
SNPs were associated with diastolic blood pressure
(rs1378942 in CSK, rs653178 in ATXN2 and rs3184504
in SH2B3), two with type 1 diabetes (rs9388489 in
C6orf97 and rs3184504 in SH2B3), as well as one each
with a lipid trait (rs174579 in FADS2), body mass index
(rs6499640 in FTO), folate pathway (rs602662 in FUT2)
and inflammation (rs4796217 in CCL4L2). The world
maps in Figure 3 show significant variation in the geo-
graphical distributions of the RAFs of eight SNPs with a
significantly higher global FST. Correction for minor
allele frequency led to another four SNPs (rs17696736,
rs2237892, rs7578597, and rs673548) reaching statistical
significance (Additional file 5).
We also plotted the patterns of pairwise FST for these
eight SNPs in any two of 52 populations and any two of
seven geographic areas (Additional file 6). The patterns
of population differentiation revealed the specific pattern
of frequency difference of each disease-susceptibility var-
iant among the world’s populations. For example, the
low RAF of rs174570 in FADS2 (associated with LDL,
HDL and total cholesterol and triglycerides) in the indi-
genous populations of America (0.038) might contribute
to the significant population differentiation between
America and any of the populations in the other six
geographic regions (ie, 393 (29.6%) pairwise compari-
sons showed a significantly higher FST). The three SNPs
A. Distribution of FST of 158 SNPs
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Figure 2 Distribution of FST. A. Distribution of FST of 158 SNPs associated with cardiovascular diseases and related intermediate traits. The
vertical bar shows the mean of global FST of these 158 SNPs (FST = 0.1042). B. Distribution of empirical global mean FST of 158 autosomal SNPs
randomly sampled from HGDP database 1000 times. The distribution of minor allele frequency of the randomly selected 158 SNPs was matched
to the observed 158 SNPs. The vertical bar shows the mean of global FST of 158 SNPs associated with cardiovascular diseases and related
intermediate traits (FST = 0.1042). C. Distribution of empirical global FST of 2,036 markers assumed to be neutral, genotyped in 938 unrelated
individuals form HGDP. Two vertical lines indicate 95% and 99% percentile of the global FST distribution. The vertical bars show the values of
global FST value of 158 susceptibility SNPs in the present study.
Table 1 A list of SNPs with significantly higher global FST (P < 0.05)
SNPs Trait Gene RAF Global FST P value Pcor
rs1378942 Diastolic blood pressure [17] CSK 0.708 (G) 0.247 0.025 0.022
rs653178 Diastolic blood pressure [17] ATXN2 0.177 (G) 0.205 0.049 0.031
rs174570 Total, HDL and LDL cholesterol [36] FADS2 0.730 (C) 0.351 0.002 0.000
rs4796217 Macrophage-mediated inflammation [37] CCL4L2 0.425 (T) 0.221 0.040 0.032
rs602662* Folate pathway [22,38] FUT2 0.294 (A) 0.240 0.027 0.028
rs9388489 Type 1 diabetes [39] C6orf97 0.634 (G) 0.308 0.008 0.002
rs3184504* Type 1 diabetes [39]; diastolic blood pressure and systolic blood pressure[17] SH2B3 0.179 (T) 0.210 0.045 0.031
rs6499640 BMI and weight[40] FTO 0.455 (A) 0.208 0.045 0.037
RAF: risk allele frequency; Pcor, P value after correcting for minor allele frequency; CSK, c-src tyrosine kinase; ATXN2, ataxin 2; FADS2, fatty acid desaturase 2;
CCL4L2, chemokine (C-C motif) ligand 4-like 2; FUT2, fucosyltransferase 2; C6orf97, chromosome 6 open reading frame 173; SH2B3, SH2B adaptor protein 3; FTO,
fat mass and obesity associated
*, non-synonymous SNPs
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blood pressure [17] showed different patterns of popula-
tion differentiation: RAFs in rs1378942 were > 0.5 in
most geographic regions (except in Middle East and
Europe); whereas RAFs in rs653178 and rs3184504 were
relatively higher in Middle East and Europe compared
to the remaining geographic regions (<0.1). Pairwise
comparisons (in any two out of seven geographic areas)
revealed differences in RAFs for more than half of the
SNPs (84 out of 158) that might be due to genetic drift
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Figure 3 Geographical distribution of risk (black) and wild-type (white) alleles in eight SNPs with a significantly higher FST among the
52 populations. In each subplot, the radius of a pie chart represents the sample size in a given population. The inserted barplot shows the
average frequency of the risk allele among the seven geographic regions. From left to right, the bars indicate Africa, Middle East, Europe, Central
South Asia, East Asia, America, and Oceania, respectively.
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significantly higher FST in pairwise comparisons among
seven geographic areas is shown in Additional file 7.
The results indicate that for risk alleles, East Asia is
more differentiated from other geographic areas.
Furthermore, in comparing any two of the 52 popula-
tions, for each SNP, at least one pairwise population
showed a significantly higher pairwise FST.T h em o s t
undifferentiated SNP among the 52 populations was
rs6511720 in LDLR, the RAF (0.921) being relatively
high worldwide, as discussed above.
Geographic patterns of population differentiation
Genetic differentiation increases with geographic dis-
tance [18], and we therefore tested whether the FST (as
am e a s u r eo fg e n e t i c‘distance’) is correlated with the
geographic distance. For each SNP, a linear regression
analysis between genetic distances and geographic dis-
tances between populations was performed. When com-
bining data from 158 SNPs, the coefficient of correlation
(R
2)w a s0 . 2 7 1( P <2 . 2×1 0
-16). When each SNP was
analyzed separately, all but five SNPs [ie, rs13194491,
rs2383208, rs2476601, rs4900384, and rs693] showed a
correlation between genetic ‘distance’ and geographic
distance.
iHS statistic
The iHS statistic is based on the differential levels of LD
surrounding a positively selected allele compared to a
background allele at the same position [16]. Voight et
al. [16] defined iHS < -1.5 or iHS > 1.5 as suggestive evi-
dence for natural selection, and iHS < -2 or iHS > 2 as
strong evidence for selection for variants that have not
yet reached fixation. Using the HGDP selection browser
[14,15], we found that of the eight SNPs listed in Table
1, rs1378942 showed strong evidence for selection (iHS
= 2.11 in America and iHS = 2.09 in Oceania); and
three SNPs showed suggestive evidence of natural selec-
tion (rs653178, iHS = 1.53 in Europe; rs9388489, iHS =
1.97 in Oceania; and rs3184504, 1.99 in Europe and 1.83
in Middle East).
Discussion
I nt h ep r e s e n ts t u d yw eu s e dg e n o t y p ed a t af r o m5 2
populations in the Human Genome Diversity Project
(HGDP) to characterize the worldwide patterns of risk
allele frequencies (RAFs) of 158 common SNPs asso-
ciated with cardiovascular diseases and related quantita-
tive traits. Our null hypothesis was that there is no
variation of RAFs of SNPs associated with cardiovascular
diseases and intermediate phenotypes, among the popu-
lations. Out of 158 susceptibility SNPs, substantial varia-
tions in RAFs of such SNPs were noted among the 52
populations, including some risk alleles being fixed or
missed in at least one population. In addition we found
that eight SNPs showed significant differences of RAFs
among the seven geographic areas. These findings pro-
vide insights into the ‘global’ genetic epidemiology of
cardiovascular disease.
Maximum differences in RAFs between any 2 popula-
t i o n sr a n g e df r o m0 . 0 8 9t o1 . 0 0 0a c r o s sS N P sw i t ha
mean of 0.661 (Figure 1A). In comparison with the rest
of world, large differences in RAFs (ie, ΔF >0 . 3o rΔF <
-0.3) were noted for the regions of Africa, East Asia,
America, and Oceania (Additional file 4 and Figure 1B),
consistent with the out-of-Africa hypothesis. Several
explanations can be put forth for the larger differences in
RAFs, including either demographic changes or shared
selective events. Hofer et al. [6] suggested that large allele
frequency differences between human continental groups
are more likely to have occurred by genetic drift during
population expansion after a bottleneck, than by selec-
tion. Using all the 158 SNPs sampled from the HGDP
database, we also calculated Nei’s genetic distances by
‘dist.genet’ function in the ‘ade4’ package [19] in R and
then used multidimensional scaling (MDS) (by ‘cmdscale’
function in R) to assess population differences (Addi-
tional file 8). The MDS shows differentiation among the
populations corresponding to the three main clusters (ie,
Europeans, Africans, and Asians). Analysis of molecular
variance (AMOVA) [20] using the ‘amova’ function in
the ‘pegas’ package [21] in R showed that, of the total var-
iance, 28.6% was due to variance among the seven geo-
graphic regions, 18.4% was due to variance among the
populations within geographic regions, and the remaining
(53.0%) was due to variance among individuals within
populations (Additional file 9).
T h es u s c e p t i b i l i t yv a r i a n t s analyzed in the present
study are likely functional variants (or in linkage dise-
quilibrium with the causal variants). The large differ-
ences in RAFs might be due to either natural selection
or population demography. For example, the non-synon-
ymous SNP rs602662 within FUT2 is in strong linkage
disequilibrium with a non-sense mutation (rs601338), a
plausible causal variant [22]. SNP rs3184504 is located
in exon 3 of SH2B3 which encodes the T-cell adapter
protein LNK [23] and might be a causal variant
(Table 1). The association of the other six SNPs has
been replicated in multiple cohorts or independent sam-
ples, suggesting they are likely to be ‘true’ associated
loci. We found additional evidence for recent positive
selection (based on iHS) [16] in four (rs1378942,
rs653178, rs9388489, and rs3184504) of these eight
SNPs. An elevated iHS score suggests that the ancestral
allele itself or the selected allele hitchhiking with the
ancestral allele may be the target of selection. The iHS
for each of the four SNPs was positive, indicating that
the ancestral allele was under selection.
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population differentiation for cardiovascular disease sus-
ceptibility SNPs identified in GWAS (Figure 2B). The
mean global FST of the 158 SNPs (0.1042) was not
significantly higher than the FST for random markers.
Lohmueller et al. [24] found that 48 SNPs associated
with common diseases were not s i g n i f i c a n t l ym o r ed i f -
ferentiated across populations than random SNPs, and
in another study of 25 disease-associated SNPs identified
in GWAS, the mean global FST ( 0 . 1 0 0 )w a sn o ts i g n i f i -
cantly higher than random SNPs in the genome [13].
Using FST and iHS, Southam et al. [25] did not find
consistent patterns of selection to confirm the ‘thrifty-
genotype’ hypothesis for metabolic syndrome/diabetes
based on HapMap data.
It should be noted that, after correction for multiple
comparison either by Bonferroni method or false discov-
ery rate, only one SNP (rs174540) remained significant.
Therefore population history and demography are likely
to explain most of the difference in RAFs among popu-
lations. However, in previous studies, signatures of nat-
ural selection have also been noted in FTO (iHS =
1.991) [25], FUT2 [26], ATXN2 (high levels of LD) [27],
and SH2B3 (iHS = -2.02 for SNP rs3184504) [15]. The
non-synonymous SNP rs3184504 in SH2B3 associated
with higher diastolic blood pressure (minor allele ‘T’)
may be under recent positive selection [17]. In the Hap-
Map samples, this derived T allele has been shown to
occur on a long haplotype (~1.5 MB) (iHS = -2.76, P <
0.006) [16], and local selection was noted (ie, FST =
0.260 for CEU-YRI comparison and FST = 0.290 for
CEU-JPT/CHB comparison). The present analysis con-
firmed that in the HGDP sample, significant population
differentiation (FST = 0.207, P = 0.048) could be attribu-
ted to a relatively higher RAF in the Middle East and
Europe. A high global FST for rs7901695 of TCF7L2
(0.361) was noted in the HapMap samples [25], but not
in the HGDP sample (0.188), possibly related to differ-
ences in sample selection between HapMap and HGDP.
Coop et al. [28] examined the role of geography and
population history in the spread of selectively favored
alleles, using the HapMap and HGDP databases, and
argued that strong, sustained selection that drives alleles
from low frequency to near fixation has been relatively
rare during the past ~70,000 years [28]. The importance
of geography on patterns of genetic variation has been
established in previous studies [9,29-31]. We examined
the prevalence of large RAFs between geographic
regions and noted that RAFs of three SNPs with a sig-
nificantly higher global FST are quite low (high)/even
missed (fixed) in several populations (Figure 3). Spatial
and/or temporal variation of selective pressures, such as
pathogens, climate or diet, may have restricted local
selection to particular populations or environments [32].
The ‘ancestral-susceptibility’ hypothesis for common
‘complex’ diseases [33] states that the ancestral allele is
maladaptive in the modern environment and associated
with increased disease susceptibility. We found that the
ancestral allele was the risk allele in 65 out of 158 SNPs
(41.1%) based on dbSNPs and UCSC database. Thus, a
subset of the cardiovascular disease susceptibility SNPs
conforms to the hypothesis of ‘ancestral susceptibility
model’ for common ‘complex’ diseases.
Geographic variation in the prevalence of phenotypes
of medical relevance can partly be due to differential
RAFs among different populations. Levels of total and
LDL cholesterol in the Pima Indians (living in central
and southern Arizona and Sonora (Mexico)) are lower
than in populations of European origin [34]. The risk
allele of rs174570 in FADS2 (a gene that regulates unsa-
turation of fatty acids) is missed in Pima (RAF = 0.000),
but fixed in Africans (RAF = 1) (Figure 3), raising the
possibility that the low RAFs of SNPs may contribute to
the low LDL cholesterol levels in Pima Indians. Pairwise
comparison of RAFs among 52 populations and seven
geographic areas indicated a high population differentia-
tion between American and non-Americans, consistent
with a previous study [35] showing Native Americans
have greater differentiation than populations from other
continental regions.
Several limitations of our study need to be mentioned.
There is a potential for bias in selecting SNPs from the
GWAS database as well as from the HGDP database.
The SNPs were selected based on GWAS in populations
of European ancestry and we were not able to character-
ize the patterns of geographic difference of RFs for SNPs
ascertained in other specific populations, such as Afri-
cans and Asians. In addition, the majority of the HGDP
populations are poorly represented in the genotyping
chips and only 158 out of 292 SNPs have been geno-
typed in HGDP [9]. The genotyping platforms used in
published GWAS varied and there was no standard
threshold in declaring significant hits. Ascertainment
bias in Oceania should be noted since only two popula-
tions (Papuan and NAN Melanesian) were sampled in
this geographic region. Nonetheless the present study
highlights a novel approach to understanding the global
genetic epidemiology of cardiovascular disease, the lead-
ing cause of death worldwide and is also a step towards
understanding the evolutionary genetics of this disease.
Conclusions
In conclusion, large differences in common SNPs that
influence risk of cardiovascular disease were noted
among the worldwide populations and are mostly due to
genetic drift. The global mean FST for these SNPs did
not differ significantly from random variants in the gen-
ome. However, pairwise comparisons revealed
Ding and Kullo BMC Medical Genetics 2011, 12:55
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Page 7 of 9differences in RAFs in eight SNPs that might be due to
local natural selection or demographic factors. These
findings may help to better understand geographic varia-
tion in the prevalence of cardiovascular disease.
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